Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candicort vs Baycuten N for Fungal Infections
NCT02582177Phase 3Completed
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jun 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Candicort in superficial mycosis and dermatophytosis (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Percentage change in the total score of signs and symptoms at 6 days. Started Jun 2019; status: completed.
02
Drugs
Candicort
03
Conditions
superficial mycosisdermatophytosis
Beyond the preview
Go deeper on NCT02582177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582177.